The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study-Reference-Cited by-同舟云学术

The 6‐minute walk test and other clinical endpoints in duchenne muscular dystrophy: Reliability, concurrent validity, and minimal clinically important differences from a multicenter study

Published:2013-07-17 Issue:3 Volume:48 Page:357-368
ISSN:0148-639X
Container-title:Muscle & Nerve
language:en
Short-container-title:Muscle Nerve

Author:

McDonald Craig M.¹,Henricson Erik K.¹,Abresch R. Ted¹,Florence Julaine²,Eagle Michelle³,Gappmaier Eduard⁴,Glanzman Allan M.⁵,Spiegel Robert⁶,Barth Jay⁶,Elfring Gary⁶,Reha Allen⁶,Peltz Stuart W.⁶,

Affiliation:

1. Department of Physical Medicine and RehabilitationNeuromuscular Medicine and Rehabilitation Research Center, University of California Davis School of MedicineDavis California95817 USA

2. Department of NeurologyWashington University School of MedicineSt. Louis Missouri USA

3. Institute of Genetic Medicine, Newcastle UniversityNewcastle upon Tyne UK

4. Department of Physical TherapyUniversity of Utah School of MedicineSalt Lake City Utah USA

5. Department of Physical TherapyChildren's Hospital of PhiladelphiaPhiladelphia Pennsylvania USA

6. PTC Therapeutics, South Plainfield New Jersey USA

Publisher

Wiley

Subject

Physiology (medical),Cellular and Molecular Neuroscience,Neurology (clinical),Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mus.23905

Reference78 articles.

1. Dystrophin: The protein product of the duchenne muscular dystrophy locus

2. Evidence-based path to newborn screening for duchenne muscular dystrophy

3. Prevalence of Duchenne/Becker muscular dystrophy among males aged 5–24 years—four states 2007. MMWR Morb Mortal Wkly Rep 2009;58:1119–1122.

4. Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management

5. Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care

Cited by 247 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intrathecal nusinersen treatment in a Chinese patient with spinal muscular atrophy type 3 after ventriculo-peritoneal shunt placement: A case report and review of literature;Brain and Development Case Reports;2024-12

2. Feasibility and Reproducibility of Isokinetic Dynamometry in Children with Neuromuscular Diseases;Journal of Clinical Medicine;2024-09-06

3. Skeletal muscle symptoms and quantitative MRI in females with dystrophinopathy;Muscle & Nerve;2024-09-02

4. Large scale serum proteomics identifies proteins associated with performance decline and clinical milestones in Duchenne muscular dystrophy;2024-08-07

5. “If you cannot measure it, you cannot improve it”. Outcome measures in Duchenne Muscular Dystrophy: current and future perspectives;Acta Neurologica Belgica;2024-07-31